PREMPHASE (PREMARIN;CYCRIN 14/14) Drug Patent Profile
✉ Email this page to a colleague
When do Premphase (premarin;cycrin 14/14) patents expire, and what generic alternatives are available?
Premphase (premarin;cycrin 14/14) is a drug marketed by Wyeth Pharms Inc and is included in one NDA.
The generic ingredient in PREMPHASE (PREMARIN;CYCRIN 14/14) is estrogens, conjugated; medroxyprogesterone acetate. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estrogens, conjugated; medroxyprogesterone acetate profile page.
Anatomical Therapeutic Chemical (ATC) Classes for PREMPHASE (PREMARIN;CYCRIN 14/14)
US Patents and Regulatory Information for PREMPHASE (PREMARIN;CYCRIN 14/14)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Pharms Inc | PREMPHASE (PREMARIN;CYCRIN 14/14) | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020303-002 | Dec 30, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PREMPHASE (PREMARIN;CYCRIN 14/14)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Wyeth Pharms Inc | PREMPHASE (PREMARIN;CYCRIN 14/14) | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020303-002 | Dec 30, 1994 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PREMPHASE (PREMARIN;CYCRIN 14/14)
See the table below for patents covering PREMPHASE (PREMARIN;CYCRIN 14/14) around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Luxembourg | 90343 | ⤷ Sign Up | |
Netherlands | 300022 | ⤷ Sign Up | |
Germany | 19775086 | ⤷ Sign Up | |
Germany | 3486442 | ⤷ Sign Up | |
Philippines | 24052 | A METHOD OF HORMONAL TREATMENT OF PERIMENOPAUSAL,MENOPAUSAL AND POST-MENOPAUSAL DISORDERS | ⤷ Sign Up |
Denmark | 175317 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for PREMPHASE (PREMARIN;CYCRIN 14/14)
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0136011 | 99C0003 | Belgium | ⤷ Sign Up | PRODUCT NAME: ESTRADIOL AND NORETHISTERONE; FIRST REGISTRATION NO/DATE: 403 IS 106 F3 19980928; FIRST REGISTRATION: SE 14007 19980306 |
0136011 | SPC/GB97/032 | United Kingdom | ⤷ Sign Up | SPC/GB97/032: 20040802, EXPIRES: 20090801 |
0136011 | 980038 | Netherlands | ⤷ Sign Up | 980038, 20090801, EXPIRES: 20130305 |
0136011 | 91096 | Luxembourg | ⤷ Sign Up | 91096, EXPIRES: 20090802 |
0136011 | C00136011/03 | Switzerland | ⤷ Sign Up | PRODUCT NMAE: ESTRADIOL UND MEDROXYPROGESTERONACETAT; REGISTRATION NO/DATE: IKS 55288 20000417 |
0136011 | SPC/GB00/028 | United Kingdom | ⤷ Sign Up | SPC/GB00/028: 20040802, EXPIRES: 20090801 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |